SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-193253
Filing Date
2019-07-12
Accepted
2019-07-12 16:41:55
Documents
1
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FINANCIAL INVESTMENT CAYMAN LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D d758512dsc13da.htm SC 13D/A 74452
  Complete submission text file 0001193125-19-193253.txt   76117
Mailing Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (441) 295-5950
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-89732 | Film No.: 19953348
SIC: 2834 Pharmaceutical Preparations